Top

Annals of Surgical Oncology

Published in:

01-01-2020 | Gastrectomy | Peritoneal Surface Malignancy

Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer

Authors: Hayemin Lee, MD, Han Hong Lee, MD, PhD, Kyo Young Song, MD, PhD, Cho Hyun Park, MD, PhD, Junhyun Lee, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2020

Abstract

Background

Endoscopic submucosal dissection (ESD) for gastric cancer produces an artificial ulcer, and negative effects on the surgical outcomes of additional gastrectomy after ESD are anticipated. The aim of this study is to analyze the effect of ESD on subsequent laparoscopic radical gastrectomy procedures and to compare the surgical results of post-ESD patients with the control group using propensity score (PS) methods.

Patients and Methods

From 2013 to 2018, 1446 patients underwent totally laparoscopic distal gastrectomy in our center. Among these patients, the clinicopathological factors and short-term surgical outcomes of 107 patients who underwent ESD before surgery (the ESD group) were evaluated. A 1:4 PS matching and inverse probability weighting method was utilized to compare the short-term surgical outcomes of the ESD group with those of a matched control group.

Results

A longer operation time was required for the patients who underwent gastrectomy earlier than 24 days after ESD than for the patients who did not. Patients whose ulcer size, due to previous ESD, exceeded 4.6 cm required longer operation times and exhibited more intraoperative blood loss than patients whose ulcer size was small. In the PS matching analysis, patients who underwent distal gastrectomy within 24 days after ESD showed more frequent postoperative morbidity than non-ESD patients.

Conclusions

ESD after laparoscopic distal gastrectomy is largely safe in terms of short-term surgical outcomes, but a short interval between the two procedures and a large ESD scar can make subsequent operation difficult.

Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Prediction of cancer incidence and mortality in Korea, 2014. Cancer Res Treat. 2014;46:124–30. https://doi.org/10.4143/crt.2014.46.2.124.CrossRefPubMedPubMedCentral

Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46:109–23. https://doi.org/10.4143/crt.2014.46.2.109.CrossRefPubMedPubMedCentral

Choi KS, Jun JK, Suh M, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer. 2015;112:608–12. https://doi.org/10.1038/bjc.2014.608.CrossRefPubMed

Ryu SJ, Kim BW, Kim BG, et al. Endoscopic submucosal dissection versus surgical resection for early gastric cancer: a retrospective multicenter study on immediate and long-term outcome over 5 years. Surg Endosc. 2016;30:5283–9. https://doi.org/10.1007/s00464-016-4877-y.CrossRefPubMed

Chiu PW, Teoh AY, To KF, et al. Endoscopic submucosal dissection (ESD) compared with gastrectomy for treatment of early gastric neoplasia: a retrospective cohort study. Surg Endosc. 2012;26:3584–91. https://doi.org/10.1007/s00464-012-2371-8.CrossRefPubMed

Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10:1–11. https://doi.org/10.1007/s10120-006-0408-1.CrossRefPubMed

Choi KS, Jung HY, Choi KD, et al. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc. 2011;73:942-8 https://doi.org/10.1016/j.gie.2010.12.032.CrossRefPubMed

Park CH, Shin S, Park JC, et al. Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis. 2013;45:651–6. https://doi.org/10.1016/j.dld.2013.01.014.CrossRefPubMed

Nishizawa T, Yahagi N. Long-term outcomes of using endoscopic submucosal dissection to treat early gastric cancer. Gut Liver. 2018;12:119–24. https://doi.org/10.5009/gnl17095.CrossRefPubMed

10.

Sunagawa H, Kinoshita T, Kaito A, et al. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases. Surg Today. 2017;47:202–9. https://doi.org/10.1007/s00595-016-1353-1.CrossRefPubMed

11.

Tanabe S, Ishido K, Higuchi K, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer. 2014;17:130–6. https://doi.org/10.1007/s10120-013-0241-2.CrossRefPubMed

12.

Suzuki S, Gotoda T, Hatta W, et al. Survival benefit of additional surgery after non-curative endoscopic submucosal dissection for early gastric cancer: a propensity score matching analysis. Ann Surg Oncol. 2017;24:3353–60. https://doi.org/10.1245/s10434-017-6039-4.CrossRefPubMed

13.

Ishida R, Kanaji S, Maehara R, et al. Significance of additional gastrectomy including endoscopic submucosal dissection scar for gastric cancer. Anticancer Res. 2018;38:5289–94. https://doi.org/10.21873/anticanres.12855.CrossRef

14.

Suzuki H, Oda I, Abe S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer. 2017;20:679–89. https://doi.org/10.1007/s10120-016-0651-z.CrossRefPubMed

15.

Akagi T, Shiraishi N, Hiroishi K, Etoh T, Yasuda K, Kitano S. Case series of intra-abdominal adhesions induced by artificial ulceration after endoscopic submucosal dissection before additional laparoscopic gastrectomy. Gastrointest Endosc. 2010;72:438–43. https://doi.org/10.1016/j.gie.2010.03.1066.CrossRefPubMed

16.

Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19. https://doi.org/10.1007/s10120-016-0622-4.

17.

Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69:345–57. https://doi.org/10.1016/j.jacc.2016.10.060.CrossRefPubMed

18.

Lee S, Choi KD, Han M, et al. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer. 2018;21:490–9. https://doi.org/10.1007/s10120-017-0772-z.CrossRefPubMed

19.

Toyokawa T, Ohira M, Tanaka H, et al. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surg Endosc. 2016;30:2404–14. https://doi.org/10.1007/s00464-015-4491-4.CrossRefPubMed

20.

Lee EG, Ryu KW, Eom BW, et al. The effect of endoscopic resection on short-term surgical outcomes in patients with additional laparoscopic gastrectomy after non-curative resection for gastric cancer. J Gastric Cancer. 2017;17:33–42. https://doi.org/10.5230/jgc.2017.17.e4.CrossRefPubMedPubMedCentral

21.

Tsuchiya I, Kato Y, Tanida E, et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial. Dig Endosc. 2017;29:576–83. https://doi.org/10.1111/den.12857.CrossRefPubMed

22.

Tomita T, Kim Y, Yamasaki T, et al. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2012;27:1441–6. https://doi.org/10.1111/j.1440-1746.2012.07144.x.CrossRefPubMed

23.

Higuchi K, Takeuchi T, Uedo N, et al. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study. Gastric Cancer. 2015;18:612–7. https://doi.org/10.1007/s10120-014-0404-9.CrossRefPubMed

24.

Shimozato A, Sasaki M, Ogasawara N, et al. Risk factors for delayed ulcer healing after endoscopic submucosal dissection of gastric neoplasms. J Gastrointest Liver Dis. 2017;26:363–8. https://doi.org/10.15403/jgld.2014.1121.264.kas.

Title: Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer
Authors: Hayemin Lee, MD
Han Hong Lee, MD, PhD
Kyo Young Song, MD, PhD
Cho Hyun Park, MD, PhD
Junhyun Lee, MD, PhD
Publication date: 01-01-2020
Publisher: Springer International Publishing
Keywords: Gastrectomy
Gastric Cancer
Gastric Cancer
Gastrectomy
Published in: Annals of Surgical Oncology / Issue 1/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-019-07962-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer

Abstract

Background

Patients and Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Patients and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC

Diaphragmatic Peritoneal Stripping Versus Full-Thickness Resection in CRS/HIPEC: Is There a Difference?

Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study

Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)

50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience

ASO Author Reflections: Surgical Margins for Melanoma—What’s Next?